|Systematic (IUPAC) name|
|Oral, rectal, intramuscular|
|Biological half-life||7 to 9 hours (mean)|
|Molar mass||388.458 g/mol[[Script error: No such module "String".]]|
Trimethobenzamide (Tebamide, Tigan) is an antiemetic used to prevent nausea and vomiting. It is often prescribed for patients with gastroenteritis, medication-induced nausea, and other illnesses. Trimethobenzamide is generally considered the most potent antiemetic that does not have effects on the serotonergic, dopaminergic, or histaminergic systems, so it has a lower likelihood of causing undesired side effects. In the United States, it requires a prescription.
Mechanism of action
Trimethobenzamide is marketed under the brand names Tebamide and Tigan, manufactured by GlaxoSmithKline and King Pharmaceuticals, respectively. It is available as oral capsules and injectable formulations.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />